Study: Cholesterol was lowered with an oral PCSK9 inhibitor.

Published Date: 08 Mar 2023

A new study conducted by Baylor College of Medicine and presented at the American College of Cardiology Annual Scientific Session as well as the World Congress of Cardiology shows that an oral PCSK9 inhibitor called MK-0616...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

WHO releases new R&D landscape analyses highlighting gaps and inequities in cancer research

2.

NHS Offers Targeted Radiotherapy for Early Prostate Cancer

3.

The September 2018 issue of Medical Bulletin.

4.

An FDA panel supports the use of CAR T-cell therapy earlier in the treatment of multiple myeloma.

5.

What are the factors that cause oral mucositis to be severe after receiving radiation for head and neck cancer?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot